Park Circle Company’s Pfizer PFE Stock Holding History

Park Circle Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94M	Hold	122,105	–	–	2.51%	12
2026 Q1	$3.43M	Sell	122,105 -600	-0.5%	-$16K	3.18%	8
2025 Q4	$3.06M	Hold	122,705	–	–	2.64%	11
2025 Q3	$3.13M	Buy	122,705 +39,205	+47%	+$968K	2.62%	11
2025 Q2	$2.02M	Buy	83,500 +65,900	+374%	+$1.54M	1.72%	16
2025 Q1	$446K	Hold	17,600	–	–	0.39%	49
2024 Q4	$467K	Hold	17,600	–	–	0.42%	46
2024 Q3	$509K	Sell	17,600 -8,500	-33%	-$248K	0.45%	44
2024 Q2	$730K	Hold	26,100	–	–	0.7%	36
2024 Q1	$724K	Buy	26,100 +17,000	+187%	+$472K	0.66%	34
2023 Q4	$262K	Hold	9,100	–	–	0.24%	60
2023 Q3	$302K	Hold	9,100	–	–	0.28%	51
2023 Q2	$334K	Hold	9,100	–	–	0.31%	50
2023 Q1	$371K	Hold	9,100	–	–	0.36%	49
2022 Q4	$466K	Hold	9,100	–	–	0.44%	47
2022 Q3	$398K	Hold	9,100	–	–	0.41%	53
2022 Q2	$477K	Hold	9,100	–	–	0.39%	57
2022 Q1	$471K	Hold	9,100	–	–	0.39%	52
2021 Q4	$537K	Hold	9,100	–	–	0.42%	49
2021 Q3	$391K	Hold	9,100	–	–	0.3%	63
2021 Q2	$356K	Hold	9,100	–	–	0.27%	57
2021 Q1	$330K	Buy	9,100 +600	+7%	+$21.3K	0.28%	54
2020 Q4	$313K	Buy	+8,500	New	+$312K	0.3%	51

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Park Circle Company's PFE Position: Q2 2026 in Review

Park Circle Company held its Pfizer (PFE) position steady in Q2 2026 at 122,105 shares worth $2.94M. The position accounts for 2.51% of the portfolio, ranked #12.

Park Circle Company first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.43M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Park Circle Company held 122,105 shares of Pfizer worth $2.94M as of Q2 2026.
Park Circle Company left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 2.51% of Park Circle Company's portfolio in Q2 2026, its #12 holding.
Park Circle Company first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
Park Circle Company's Pfizer position peaked at $3.43M in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Park Circle Company's 13F filing for Q2 2026, filed 13 Aug 2026.